|
March 15-16, 2001 Meeting
Date and Time
The meeting will be held on March 15-16, 2001, beginning at 8:00 a.m. on both days.
Location
Hilton Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877, 301-977-8900.
Contact Person
Linda A. Smallwood, Ph.D., 301-827-3514, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 19516. Please call the Information Line for up-to-date information on this meeting.
Agenda
On March 15, 2001, the committee will hear presentations, discuss and make recommendations on the Abbott Prism Test System: Informational presentation only, and the Comparative Sensitivity of Hepatitis B Virus Nucleic Acid Testing (HBV NAT) vs. Hepatitis B Surface Antigen (HBsAg) testing. In the afternoon the committee will hear presentations, discuss and make recommendations on the Implementation of Nucleic Acid Testing (NAT) for Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): Donor and Product Management, and Blood Bags for Diversion of the Initial Collection. On March 16, 2001, the committee will hear updates on the following topics: summaries of the Transmissible Spongiform Encephalopathies Advisory Committee Meeting and the PHS Advisory Committee on Blood Safety and Availability, and the Office of Inspector General Report on Tissue and Organ Regulation. In the morning, the committee will hear presentations, discuss and make recommendations on Male to Male Sex (MSM) Deferral Recommendations for Blood and Tissue Donors, Including Semen for Artificial Insemination, and in the afternoon, Guidance on Malaria: Applicability to Plasma.
Oral Presentations
Between approximately 9:00 to 9:15 a.m., 10:30 to 11:00 a.m., 1:30 to 2:30 p.m., and 4:30 to 4:45 p.m. on March 15, 2001; and from 9:30 to 10:30 a.m., and 2:30 to 2:45 p.m. on March 16, 2001 oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before March 5, 2001.
|
